Clinical Trial Update: Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 open-label safety study evaluating chronic exposure to CLONICEL (clonidine hydrochloride sustained-release) in children and adolescents with ADHD; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CLONICEL (clonidine sustained-release)

Snippet

Sponsor: Shionogi | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-02-27